Juan Carlos Aranda Crisólogo

Juan Carlos Aranda Crisólogo

Auto-generated profile, based on publicly available information

Juan Carlos Aranda Crisólogo

Hospital Regional Docente de Cajamarca, Intensive Care. Cajamarca, Perú

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2025 in Sapienza: International Journal of Interdisciplinary Studies
Verified
Journal Article
Open access
LLLuis Eduardo Morillo Lemus
Luis Eduardo Morillo Lemus
LPLincoln Xavier Naranjo Palacio
Lincoln Xavier Naranjo Palacio
JCJuan Carlos Aranda Crisólogo
Juan Carlos Aranda Crisólogo
ZMZeus Edrian Daniel Alfonso González Mercado
Zeus Edrian Daniel Alfonso González Mercado
GOGabriela Gomez Orozco
Gabriela Gomez Orozco
CFChristopher Giovanni Vega Flores
Christopher Giovanni Vega Flores
Background: Implant-based breast reconstruction (IBBR) is the most common post-mastectomy reconstructive approach. Optimal implant placement, prepectoral (PP) versus submuscular (SP), remains debated with respect to safety, complications, and cosmetic outcomes. This review summarizes comparative evidence published since 2015 to evaluate the effectiveness and safety of these techniques. Methods: Following PRISMA, PubMed, Scopus, Web of Science, and the Cochrane Library were searched for comparative studies published between January 2015 and September 2025. Eligible studies directly compared PP and SP IBBR in adult women. Outcomes included complications, patient-reported satisfaction, and aesthetic results. Study quality was assessed using appropriate tools (e.g., MINORS), and a scientometric analysis of publication trends was performed. Results: Analysis showed that PP reconstruction significantly reduced breast animation deformity (pooled OR 0.02–0.37) and early postoperative pain compared with SP placement. PP was also associated with a moderate reduction in capsular contracture risk (pooled OR −0.54). However, PP reconstruction demonstrated higher risks of seroma (OR 1.55) and implant rippling (OR 2.39). Rates of infection, implant loss, and reoperation were generally comparable between techniques, though substantial heterogeneity was observed. Patient-reported outcomes were inconsistent, with no uniform superiority of either method across domains. Conclusions: Prepectoral IBBR offers clear advantages in reducing animation deformity and early postoperative pain, with potential benefit regarding capsular contracture, at the cost of increased seroma and rippling. Overall, major complication rates are similar, supporting PP reconstruction as a safe and effective option in selected patients. Further long-term prospective studies are needed to refine patient selection and standardize techniques.

1 January 2026 in Salud, Ciencia y Tecnología
Verified
Journal Article
Open access
PDF file
MEMarcela de Los Angeles López Escareño
Marcela de Los Angeles López Escareño
CDCesar Augusto Flores Duenas
Cesar Augusto Flores Duenas
FGFernando José Barros Gómez
Fernando José Barros Gómez
ETEstefania Collaguazo Troya
Estefania Collaguazo Troya
JCJuan Carlos Aranda Crisólogo
Juan Carlos Aranda Crisólogo
SRSebastian Andres Gonzaga Ramirez
Sebastian Andres Gonzaga Ramirez
Objective: This systematic review compares survival with favorable neurological outcomes following extracorporeal cardiopulmonary resuscitation (ECPR) versus conventional CPR (CCPR) in adults with refractory cardiac arrest.Methods: We conducted a systematic search of major databases for randomized and observational studies comparing ECPR to CCPR. The primary outcome was survival with a favorable neurological outcome, defined as a Cerebral Performance Category (CPC) of 1 or 2.Results: Eight studies involving 1,676 patients were included. The pooled analysis demonstrated that ECPR was associated with a 21.2 % rate of favorable neurological outcome compared to 16.7 % with CCPR. The combined relative risk (RR) was 1.27 (95 % CI 1.04–1.56), indicating a statistically significant 27 % relative improvement with ECPR. The absolute risk reduction was 4.5 %, with a number needed to treat of 22. However, significant heterogeneity was observed. The magnitude of benefit was highly dependent on patient and system factors, with the most pronounced advantages seen in patients with an initial shockable rhythm and shorter low-flow times. While one randomized controlled trial (ARREST) reported a large, significant effect (RR 6.43), the larger INCEPTION trial found a non-significant effect (RR 1.24).Conclusion: ECPR is associated with a significant improvement in survival with favorable neurological outcomes compared to CCPR. This benefit is not universal and appears greatest in selected populations, particularly those with shockable rhythms and rapid access to a highly organized ECPR system. Successful implementation requires robust protocols for rapid deployment and careful patient selection.

31 January 2021 in Norte Médico
Verified
Journal Article
Open access
PDF file
JCJuan Carlos Aranda Crisólogo
Juan Carlos Aranda Crisólogo
COVID-19 debe considerarse como una enfermedad sistémica que involucra múltiples sistemas humanos debido a la respuesta inflamatoria sistemática descontrolada resultante de la liberación de grandes cantidades de citocinas y quimiocinas proinflamatorias por las células efectoras inmunes, denominada “tormenta de citocinas”. El COVID 19 altera la coagulación sanguínea y puede manifestarse clínicamente en diversos órganos y sistemas alterándolos, causando, por ejemplo: microangiopatías trombóticas (MAT), lívedo reticularis en la piel. En este caso se describe principalmente estas patologías causadas por COVID 19, en el contexto de la pandemia.